Dupont Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,348
Closed -$324K 436
2023
Q2
$324K Buy
+1,348
New +$280K 0.02% 333
2023
Q1
Sell
-1,205
Closed -$256K 1023
2022
Q4
$256K Sell
1,205
-6,311
-84% -$1.26M 0.01% 727
2022
Q3
$1.18M Buy
7,516
+5,656
+304% +$903K 0.07% 316
2022
Q2
$278K Sell
1,860
-1,444
-44% -$209K 0.01% 875
2022
Q1
$541K Sell
3,304
-293
-8% -$48.3K 0.02% 715
2021
Q4
$783K Sell
3,597
-1,145
-24% -$240K 0.03% 628
2021
Q3
$898K Buy
4,742
+1,547
+48% +$282K 0.03% 639
2021
Q2
$564K Hold
3,195
0.01% 906
2021
Q1
$524K Sell
3,195
-6,882
-68% -$1.05M 0.01% 884
2020
Q4
$1.4M Sell
10,077
-11,939
-54% -$1.5M 0.03% 435
2020
Q3
$2.46M Buy
22,016
+16,640
+310% +$1.92M 0.05% 261
2020
Q2
$500K Sell
5,376
-2,227
-29% -$190K 0.01% 779
2020
Q1
$558K Sell
7,603
-8,132
-52% -$706K 0.01% 632
2019
Q4
$1.32M Hold
15,735
0.03% 473
2019
Q3
$1.32M Buy
15,735
+5,954
+61% +$450K 0.03% 447
2019
Q2
$640K Hold
9,781
0.01% 679
2019
Q1
$577K Hold
9,781
0.01% 712
2018
Q4
$518K Buy
9,781
+2,956
+43% +$162K 0.01% 714
2018
Q3
$409K Buy
+6,825
New +$373K 0.01% 750

Other funds holding MEDP

Dupont Capital Management's MEDP Position: Q3 2023 in Review

Dupont Capital Management sold out of Medpace (MEDP) in Q3 2023, closing a stake of 1,348 shares — an estimated $324K sold.

Dupont Capital Management first reported a position in MEDP in Q3 2018 and held it in 19 quarters. The position peaked at $2.46M in Q3 2020. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

  • Dupont Capital Management reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 1,348 Medpace shares in Q3 2023, an estimated $324K.
  • Dupont Capital Management first reported a position in Medpace in Q3 2018 and held it in 19 quarters.
  • Dupont Capital Management's Medpace position peaked at $2.46M in Q3 2020.
  • 488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.